Statin prescription among patients with type 2 diabetes in Botswana : findings and implications
Mwita, Julius Chacha and Godman, Brian and Esterhuizen, Tonya M. (2020) Statin prescription among patients with type 2 diabetes in Botswana : findings and implications. BMC Endocrine Disorders, 20 (1). 36. (https://doi.org/10.1186/s12902-020-0516-7)
Preview |
Text.
Filename: Mwita_etal_BMC_ED_2020_Statin_prescription_among_patients_with_type.pdf
Final Published Version License: Download (572kB)| Preview |
Abstract
Background: There is evidence of statin benefit among patients with diabetes regardless of cholesterol levels or prior cardiovascular disease history. Despite the evidence, there is under-prescription of statins in clinical practice. This study aimed to assess statin prescriptions and associated factors among patients with type 2 diabetes in Botswana. Methods: The study was a secondary data analysis of 500 randomly selected type 2 diabetes patients at a specialised diabetes clinic at Gaborone, Botswana. We assessed the proportion of statin-eligible patients who are prescribed statins and evaluated the adjusted associations between various factors and statin prescriptions.Results: Overall, 477 (95.4%) participants were eligible for a statin prescription. Clinicians prescribed statins in 217 (45.5%) of eligible participants, and only one (4.4%) ineligible participant. The probability of a statin prescription was higher in participants with high baseline low-density lipoprotein cholesterol (risk ratio [RR]: 1.49; 95%CI: 1.17-1.89), increasing duration of diabetes (RR: 1.01; 95%CI 1.00-1.03) and the presence of chronic kidney disease (RR: 1.35; 95%CI: 1.06-1.74). Conclusion: A large proportion with type 2 diabetes in Gaborone is not receiving statins. Clinicians did not consider most guideline-recommended indications for statin prescriptions. The findings call for improvement in diabetes quality of care by implementing evidence-based guideline recommendations.
-
-
Item type: Article ID code: 71712 Dates: DateEvent10 March 2020Published27 February 2020AcceptedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 06 Mar 2020 11:23 Last modified: 12 Sep 2024 00:53 URI: https://strathprints.strath.ac.uk/id/eprint/71712